1.      Porwal Auto Components Ltd.  

The meeting of the Board of Directors of the Company is scheduled on Saturday,31st January,2009,at 5.00p.m. at the registered office of the company,to interalia,consider Un-audited Quarterly Financial Results of the company for the quarter ended 31st December,2008.

 

2.      Sunehari Exports Limited  

The meeting of the board of Directors of the Company is scheduled to be held on Saturday,31st January,2009 to, inter-alia consider and take on record the Unaudited financial results (provisional)of the Company for the quarter ended 31st December 2008.

 

3.      Jayatma Spinners Limited

The meeting of the Board of Directors of the Company is scheduled to be held on Saturday,the 31st January,2009 at 1, Laxminagar co-op Housing Soc Ltd.Besides Naranpura Post office, Naranpura, Ahmedabad-13,at 6.00 Pmto consider and taje on record Unaudited Financial Results (Provisional) for the quarter ended on 31st December,2008.

 

    4.      J R D Finance Ltd.

Board Meeting to be held on 29th January,2009 to consider and take on record the unaudited financial results (provisional)for the quarter ended on 31st December,2008.

 

    5. Anglo-French Drugs & Industries Ltd.

Unaudited financial results of Anglo-French Drugs & Industries Ltd  for the quarter ended  31st December , 2008 (enclosed).

 

ANGLO-FRENCH DRUGS &INDUSTRIES LTD  
Regd. Off. : C-6, Road No. 22, MIDC, Andheri (E), Mumbai - 400 093  
Unaudited Financial Results for the year ended December 31, 2008  
   
Particulars Oct-Dec2008 Oct-Dec2007 Jul-Dec2008 Jul-Dec2007 Apr-Jun2008
-          
Net Sales/Income from operations                 2,100.00           1,942.00      4,312.00      3,695.00 8801
Less: Excise duty 123 213 277 419 925
Sales(Net) 1977 1729 4035 3276 7876
Other Income manu facturing 7 3 15 10 34
Other 50 44 97 89 254
Total 57 47 112 99 288
Total Income 2034 1776 4147 3375 8164
Increase/Decrease in Stock-in-Trade  -162 288 -290 217 146
Consumption of raw materials 937 541 1865 1253 3207
Purchase of traded goods 196 112 366 244 603
Staff Cost 344 341 690 644 1630
Depreciation 42 37 82 77 201
Other Expenditure 549 539 1151 1105 2835
Total 1906 1858 3864 3540 8622
Interest  37 71 68 141 304
Profit(+)/Loss(-) before tax 91 (-153) 215 -306 -762
Tax Expenses(Deferred) -16 -52 26 -104 -14
Deferred          
Fringe Benefit 8 5 15 11 28
Profit for the year          
Tax Adjustment for earlier years          
Net Profit (+)/Loss (-) after tax 99 -106 174 -213 -776
Extraordinary Items 0 0 0 0 1523
Net Profit/(loss) for the period 99 -106 174 -213 747
Paid up Equity Share Capital 116 116 116 116 116
Face value           
Reserves excluding revaluation reserve                            -                        -                   -                   -   1054
Eaming  per shares          
a) Basic and Diluted before extraordinary items                        8.53                 (9.06)           14.95          (18.28) -66.75
b)Basic and diluted after extraordinary items                        8.53                 (9.06)           14.95          (18.28) 64.24
Aggregate of Non-Promoter Shareholding          
Number of Shares                  550,675            551,385       550,675       551,385 551025
percentage of Shareholding 47.37% 47.43% 47.37% 47.43% 47.4
         
         
SEGMENTWISE REVENUE, RESULTS AND CAPITAL EMPLOYEED  
Particulars Quarter  ened 31.12.08 Quarter  ened 31.12.07 Six months ended 31.12.2008 Six months ended 31.12.2007 Six months ended 30.06.2008(Audited)
-          
1. Segment Revenue          
a.Pharma 1895 1577 3884 3067 7429
b.Furnishing 139 199 262 307 734
c.Unallocated 0 0 1 1 1
Total 2034 1776 4147 3375 8164
Less : Inter Segment Revenue 17 37 17 37 101
Net Sales/Income from operations 2017 1739 4130 3338 8063
Segment Results          
(Profit(+)/Loss(-) before tax and interest  from each segment)          
a.Pharma 131 -78 319 -121 -288
b.Furnishing 1 -2 -30 -40 -159
c.Unallocated 0 0 0 0 0
Total 132 -80 289 -161 -447
Less          
I)Interest (net) 37 71 68 141 304
II)Other Unallocable expenditure net of unallocable income 4 2 6 4 11
Total Profit (Loss) before tax 91 -153 215 -306 -762
Capital Employed (degment Assets segment Liabilities)          
a.Pharma 2030 1370 2030 1370 1924
b.Furnishing 599 751 599 751 607
c Unallocated 8 34 8 34 8
Total 2637 2155 2637 2155 2539

 

 

To Top Back